ID SKI3_HUMAN Reviewed; 1564 AA. AC Q6PGP7; O15077; Q6PJI3; DT 03-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 1. DT 27-MAR-2024, entry version 167. DE RecName: Full=Superkiller complex protein 3 {ECO:0000305}; DE Short=Ski3 {ECO:0000303|PubMed:32006463}; DE AltName: Full=Tetratricopeptide repeat protein 37; DE Short=TPR repeat protein 37; DE AltName: Full=Tricho-hepatic-enteric syndrome protein {ECO:0000303|PubMed:20176027}; DE Short=Thespin {ECO:0000303|PubMed:20176027}; GN Name=SKIC3 {ECO:0000312|HGNC:HGNC:23639}; GN Synonyms=KIAA0372 {ECO:0000303|PubMed:9205841}, TTC37 GN {ECO:0000303|PubMed:21120949}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=9205841; DOI=10.1093/dnares/4.2.141; RA Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N., RA Tanaka A., Kotani H., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. VII. The RT complete sequences of 100 new cDNA clones from brain which can code for RT large proteins in vitro."; RL DNA Res. 4:141-150(1997). RN [2] RP SEQUENCE REVISION. RA Ohara O., Nagase T., Kikuno R., Nomura N.; RL Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung carcinoma, and Melanoma; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PAF1, AND IDENTIFICATION RP IN THE SKI COMPLEX. RX PubMed=16024656; DOI=10.1101/gad.1292105; RA Zhu B., Mandal S.S., Pham A.D., Zheng Y., Erdjument-Bromage H., Batra S.K., RA Tempst P., Reinberg D.; RT "The human PAF complex coordinates transcription with events downstream of RT RNA synthesis."; RL Genes Dev. 19:1668-1673(2005). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [6] RP TISSUE SPECIFICITY, VARIANTS 860-ASN--GLU-878 DEL; ASP-1077; ALA-1270 AND RP ARG-1485, AND ASSOCIATION WITH THES1. RX PubMed=21120949; DOI=10.1002/humu.21420; RA Fabre A., Martinez-Vinson C., Roquelaure B., Missirian C., Andre N., RA Breton A., Lachaux A., Odul E., Colomb V., Lemale J., Cezard J.P., RA Goulet O., Sarles J., Levy N., Badens C.; RT "Novel mutations in TTC37 associated with Tricho-Hepato-Enteric syndrome."; RL Hum. Mutat. 32:277-281(2011). RN [7] RP ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [9] RP VARIANTS THES1 ARG-251; ASN-1283 AND SER-1505. RX PubMed=20176027; DOI=10.1053/j.gastro.2010.02.010; RA Hartley J.L., Zachos N.C., Dawood B., Donowitz M., Forman J., Pollitt R.J., RA Morgan N.V., Tee L., Gissen P., Kahr W.H., Knisely A.S., Watson S., RA Chitayat D., Booth I.W., Protheroe S., Murphy S., de Vries E., Kelly D.A., RA Maher E.R.; RT "Mutations in TTC37 cause trichohepatoenteric syndrome (phenotypic diarrhea RT of infancy)."; RL Gastroenterology 138:2388-2398(2010). RN [10] RP FUNCTION, AND IDENTIFICATION IN THE SKI COMPLEX. RX PubMed=32006463; DOI=10.1016/j.molcel.2020.01.011; RA Zinoviev A., Ayupov R.K., Abaeva I.S., Hellen C.U.T., Pestova T.V.; RT "Extraction of mRNA from stalled ribosomes by the Ski complex."; RL Mol. Cell 77:1340-1349(2020). RN [11] {ECO:0007744|PDB:7QDR, ECO:0007744|PDB:7QDS, ECO:0007744|PDB:7QDY, ECO:0007744|PDB:7QDZ} RP STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) IN COMPLEX WITH SKIC2 AND RP SKIC8, FUNCTION, AND IDENTIFICATION IN THE SKI COMPLEX. RX PubMed=35120588; DOI=10.1016/j.molcel.2022.01.009; RA Koegel A., Keidel A., Bonneau F., Schaefer I.B., Conti E.; RT "The human SKI complex regulates channeling of ribosome-bound RNA to the RT exosome via an intrinsic gatekeeping mechanism."; RL Mol. Cell 82:756-769(2022). CC -!- FUNCTION: Component of the SKI complex, a multiprotein complex that CC assists the RNA-degrading exosome during the mRNA decay and quality- CC control pathways (PubMed:16024656, PubMed:32006463, PubMed:35120588). CC The SKI complex catalyzes mRNA extraction from 80S ribosomal complexes CC in the 3'-5' direction and channels mRNA to the cytosolic exosome for CC degradation (PubMed:32006463, PubMed:35120588). SKI-mediated extraction CC of mRNA from stalled ribosomes allow binding of the Pelota-HBS1L CC complex and subsequent ribosome disassembly by ABCE1 for ribosome CC recycling (PubMed:32006463). In the nucleus, the SKI complex associates CC with transcriptionally active genes in a manner dependent on PAF1 CC complex (PAF1C) (PubMed:16024656). {ECO:0000269|PubMed:16024656, CC ECO:0000269|PubMed:32006463, ECO:0000269|PubMed:35120588}. CC -!- SUBUNIT: Component of the SKI complex which consists of SKIC2, SKIC3 CC and SKIC8 (PubMed:16024656, PubMed:32006463, PubMed:35120588). CC Interacts with PAF1 (PubMed:16024656). {ECO:0000269|PubMed:16024656, CC ECO:0000269|PubMed:32006463, ECO:0000269|PubMed:35120588}. CC -!- INTERACTION: CC Q6PGP7; Q8N7H5: PAF1; NbExp=2; IntAct=EBI-6083436, EBI-2607770; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16024656}. Nucleus CC {ECO:0000269|PubMed:16024656}. CC -!- TISSUE SPECIFICITY: Widely expressed with the highest levels observed CC in vascular tissues, lymph node, pituitary, lung and intestine. Not CC expressed in the liver. {ECO:0000269|PubMed:21120949}. CC -!- DISEASE: Trichohepatoenteric syndrome 1 (THES1) [MIM:222470]: A CC syndrome characterized by intrauterine growth retardation, severe CC diarrhea in infancy requiring total parenteral nutrition, facial CC dysmorphism, immunodeficiency, and hair abnormalities, mostly CC trichorrhexis nodosa. Hepatic involvement contributes to the poor CC prognosis of affected patients. {ECO:0000269|PubMed:20176027}. Note=The CC disease is caused by variants affecting the gene represented in this CC entry. CC -!- SIMILARITY: Belongs to the SKI3 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA20827.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB002370; BAA20827.2; ALT_INIT; mRNA. DR EMBL; BC015163; AAH15163.1; -; mRNA. DR EMBL; BC056893; AAH56893.1; -; mRNA. DR CCDS; CCDS4072.1; -. DR RefSeq; NP_055454.1; NM_014639.3. DR PDB; 7QDR; EM; 3.70 A; B=1-1564. DR PDB; 7QDS; EM; 3.80 A; B=1-1564. DR PDB; 7QDY; EM; 3.10 A; B=1-1564. DR PDB; 7QDZ; EM; 3.60 A; B=1-1564. DR PDBsum; 7QDR; -. DR PDBsum; 7QDS; -. DR PDBsum; 7QDY; -. DR PDBsum; 7QDZ; -. DR AlphaFoldDB; Q6PGP7; -. DR EMDB; EMD-13923; -. DR EMDB; EMD-13925; -. DR EMDB; EMD-13927; -. DR EMDB; EMD-13928; -. DR SMR; Q6PGP7; -. DR BioGRID; 115010; 116. DR ComplexPortal; CPX-2736; SKI complex. DR CORUM; Q6PGP7; -. DR IntAct; Q6PGP7; 32. DR MINT; Q6PGP7; -. DR STRING; 9606.ENSP00000497948; -. DR GlyGen; Q6PGP7; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q6PGP7; -. DR PhosphoSitePlus; Q6PGP7; -. DR SwissPalm; Q6PGP7; -. DR BioMuta; TTC37; -. DR DMDM; 74758339; -. DR EPD; Q6PGP7; -. DR jPOST; Q6PGP7; -. DR MassIVE; Q6PGP7; -. DR MaxQB; Q6PGP7; -. DR PaxDb; 9606-ENSP00000351596; -. DR PeptideAtlas; Q6PGP7; -. DR ProteomicsDB; 67118; -. DR Pumba; Q6PGP7; -. DR Antibodypedia; 48952; 30 antibodies from 16 providers. DR DNASU; 9652; -. DR Ensembl; ENST00000358746.7; ENSP00000351596.3; ENSG00000198677.13. DR Ensembl; ENST00000649566.1; ENSP00000497948.1; ENSG00000198677.13. DR GeneID; 9652; -. DR KEGG; hsa:9652; -. DR MANE-Select; ENST00000358746.7; ENSP00000351596.3; NM_014639.4; NP_055454.1. DR UCSC; uc003klb.4; human. DR AGR; HGNC:23639; -. DR CTD; 9652; -. DR DisGeNET; 9652; -. DR GeneCards; SKIC3; -. DR GeneReviews; SKIC3; -. DR HGNC; HGNC:23639; SKIC3. DR HPA; ENSG00000198677; Low tissue specificity. DR MalaCards; SKIC3; -. DR MIM; 222470; phenotype. DR MIM; 614589; gene. DR neXtProt; NX_Q6PGP7; -. DR OpenTargets; ENSG00000198677; -. DR Orphanet; 84064; Syndromic diarrhea. DR PharmGKB; PA162407226; -. DR VEuPathDB; HostDB:ENSG00000198677; -. DR eggNOG; KOG1127; Eukaryota. DR GeneTree; ENSGT00390000016407; -. DR HOGENOM; CLU_003788_1_0_1; -. DR InParanoid; Q6PGP7; -. DR OMA; CQWELDP; -. DR OrthoDB; 3076611at2759; -. DR PhylomeDB; Q6PGP7; -. DR TreeFam; TF323569; -. DR PathwayCommons; Q6PGP7; -. DR Reactome; R-HSA-429958; mRNA decay by 3' to 5' exoribonuclease. DR SignaLink; Q6PGP7; -. DR BioGRID-ORCS; 9652; 40 hits in 1159 CRISPR screens. DR ChiTaRS; TTC37; human. DR GenomeRNAi; 9652; -. DR Pharos; Q6PGP7; Tbio. DR PRO; PR:Q6PGP7; -. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; Q6PGP7; Protein. DR Bgee; ENSG00000198677; Expressed in calcaneal tendon and 208 other cell types or tissues. DR ExpressionAtlas; Q6PGP7; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0000791; C:euchromatin; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0055087; C:Ski complex; IDA:UniProtKB. DR GO; GO:0070478; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay; IDA:UniProtKB. DR GO; GO:0034427; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; IBA:GO_Central. DR GO; GO:0072344; P:rescue of stalled ribosome; IDA:UniProtKB. DR Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 8. DR InterPro; IPR039226; Ski3/TTC37. DR InterPro; IPR011990; TPR-like_helical_dom_sf. DR InterPro; IPR019734; TPR_repeat. DR PANTHER; PTHR15704; SUPERKILLER 3 PROTEIN-RELATED; 1. DR PANTHER; PTHR15704:SF7; TETRATRICOPEPTIDE REPEAT PROTEIN 37; 1. DR Pfam; PF13432; TPR_16; 2. DR Pfam; PF14559; TPR_19; 1. DR Pfam; PF13181; TPR_8; 2. DR SMART; SM00028; TPR; 14. DR SUPFAM; SSF81901; HCP-like; 2. DR SUPFAM; SSF48452; TPR-like; 5. DR PROSITE; PS50005; TPR; 12. DR PROSITE; PS50293; TPR_REGION; 5. DR Genevisible; Q6PGP7; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Nucleus; Reference proteome; Repeat; KW TPR repeat. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:22814378" FT CHAIN 2..1564 FT /note="Superkiller complex protein 3" FT /id="PRO_0000251722" FT REPEAT 6..39 FT /note="TPR 1" FT REPEAT 40..73 FT /note="TPR 2" FT REPEAT 272..305 FT /note="TPR 3" FT REPEAT 307..339 FT /note="TPR 4" FT REPEAT 386..419 FT /note="TPR 5" FT REPEAT 420..453 FT /note="TPR 6" FT REPEAT 455..492 FT /note="TPR 7" FT REPEAT 493..527 FT /note="TPR 8" FT REPEAT 564..597 FT /note="TPR 9" FT REPEAT 598..631 FT /note="TPR 10" FT REPEAT 633..665 FT /note="TPR 11" FT REPEAT 679..713 FT /note="TPR 12" FT REPEAT 790..824 FT /note="TPR 13" FT REPEAT 826..860 FT /note="TPR 14" FT REPEAT 861..894 FT /note="TPR 15" FT REPEAT 980..1013 FT /note="TPR 16" FT REPEAT 1020..1054 FT /note="TPR 17" FT REPEAT 1056..1084 FT /note="TPR 18" FT REPEAT 1326..1359 FT /note="TPR 19" FT REPEAT 1400..1433 FT /note="TPR 20" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0007744|PubMed:22814378" FT VARIANT 251 FT /note="G -> R (in THES1; dbSNP:rs763816083)" FT /evidence="ECO:0000269|PubMed:20176027" FT /id="VAR_067957" FT VARIANT 437 FT /note="L -> V (in dbSNP:rs17084873)" FT /id="VAR_027705" FT VARIANT 860..878 FT /note="Missing (found in a THES1 patient)" FT /evidence="ECO:0000269|PubMed:21120949" FT /id="VAR_065297" FT VARIANT 1077 FT /note="A -> D (found in a THES1 patient)" FT /evidence="ECO:0000269|PubMed:21120949" FT /id="VAR_065298" FT VARIANT 1270 FT /note="P -> A (found in a THES1 patient; FT dbSNP:rs146627706)" FT /evidence="ECO:0000269|PubMed:21120949" FT /id="VAR_065299" FT VARIANT 1283 FT /note="D -> N (in THES1)" FT /evidence="ECO:0000269|PubMed:20176027" FT /id="VAR_067958" FT VARIANT 1296 FT /note="R -> S (in dbSNP:rs2303650)" FT /id="VAR_027706" FT VARIANT 1485 FT /note="L -> R (found in a THES1 patient)" FT /evidence="ECO:0000269|PubMed:21120949" FT /id="VAR_065300" FT VARIANT 1505 FT /note="L -> S (in THES1; dbSNP:rs376720108)" FT /evidence="ECO:0000269|PubMed:20176027" FT /id="VAR_067959" FT HELIX 355..365 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 370..382 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 389..399 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 403..405 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 406..415 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 422..435 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 439..451 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 457..469 FT /evidence="ECO:0007829|PDB:7QDY" FT TURN 470..472 FT /evidence="ECO:0007829|PDB:7QDY" FT TURN 476..479 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 480..488 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 492..496 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 497..503 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 510..523 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 530..540 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 547..556 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 564..576 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 580..593 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 598..610 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 615..626 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 632..644 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 648..661 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 666..685 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 689..709 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 714..725 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 732..734 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 737..739 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 742..744 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 751..753 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 755..772 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 776..795 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 800..803 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 804..820 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 825..835 FT /evidence="ECO:0007829|PDB:7QDY" FT TURN 838..840 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 843..856 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 861..873 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 877..890 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 895..907 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 913..923 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 927..942 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 952..958 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 961..975 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 980..992 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 996..1009 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1017..1032 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1036..1044 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1051..1064 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1067..1079 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1085..1101 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1104..1115 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 1117..1119 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1124..1134 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1138..1151 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1160..1171 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1177..1188 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1193..1205 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1211..1223 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1229..1243 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 1251..1254 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1255..1265 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1270..1290 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1300..1312 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1318..1339 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1342..1355 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1362..1370 FT /evidence="ECO:0007829|PDB:7QDY" FT STRAND 1372..1374 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1383..1395 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1400..1413 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1416..1433 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1437..1455 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1463..1477 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1481..1493 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1499..1510 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1516..1532 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1536..1547 FT /evidence="ECO:0007829|PDB:7QDY" FT HELIX 1553..1562 FT /evidence="ECO:0007829|PDB:7QDY" SQ SEQUENCE 1564 AA; 175486 MW; 12D6B45B4A6F367A CRC64; MSSKEVKTAL KSARDAIRNK EYKEALKHCK TVLKQEKNNY NAWVFIGVAA AELEQPDQAQ SAYKKAAELE PDQLLAWQGL ANLYEKYNHI NAKDDLPGVY QKLLDLYESV DKQKWCDVCK KLVDLYYQEK KHLEVARTWH KLIKTRQEQG AENEELHQLW RKLTQFLAES TEDQNNETQQ LLFTAFENAL GLSDKIPSED HQVLYRHFIQ SLSKFPHESA RLKKACEGMI NIYPTVQYPL EVLCLHLIES GNLTDEGQQY CCRLVEMDSK SGPGLIGLGI KALQDKKYED AVRNLTEGLK ESPVCTSGWY HLAEAQVKMH RPKEAVLSCS QALKIVDNLG ASGNSLYQRN LCLHLKAEAL IKLSDYDSSE EAIRTLDQIS DADNIPGLLV LKSLAYRNKG SFDEAAKIME DLLSSYPDLA EVHALEALIH FTKKDYLQAE KCFQRALEKD TEVAEYHYQL GLTYWFMGEE TRKDKTKALT HFLKAARLDT YMGKVFCYLG HYYRDVVGDK NRARGCYRKA FELDDTDAES GAAAVDLSVE LEDMEMALAI LTTVTQKASA GTAKWAWLRR GLYYLKAGQH SQAVADLQAA LRADPKDFNC WESLGEAYLS RGGYTTALKS FTKASELNPE SIYSVFKVAA IQQILGKYKE AVAQYQMIIK KKEDYVPALK GLGECHLMMA KAALVDYLDG KAVDYIEKAL EYFTCALQHR ADVSCLWKLA GDACTCLYAV APSKVNVHVL GVLLGQKEGK QVLKKNELLH LGGRCYGRAL KLMSTSNTWC DLGINYYRQA QHLAETGSNM NDLKELLEKS LHCLKKAVRL DSNNHLYWNA LGVVACYSGI GNYALAQHCF IKSIQSEQIN AVAWTNLGVL YLTNENIEQA HEAFKMAQSL DPSYLMCWIG QALIAEAVGS YDTMDLFRHT TELNMHTEGA LGYAYWVCTT LQDKSNRETE LYQYNILQMN AIPAAQVILN KYVERIQNYA PAFTMLGYLN EHLQLKKEAA NAYQRAILLL QTAEDQDTYN VAIRNYGRLL CSTGEYDKAI QAFKSTPLEV LEDIIGFALA LFMKGLYKES SKAYERALSI VESEQDKAHI LTALAITEYK QGKTDVAKTL LFKCSILKEP TTESLQALCA LGLAMQDATL SKAALNELLK HIKHKDSNYQ RCLLTSAIYA LQGRSVAVQK QISKAVHSNP GDPALWSLLS RVVAQYAQRN AKGGVVAGNV AHILDSNHGK KALLYTAVNQ LAMGSSSAED EKNTALKTIQ KAALLSPGDP AIWAGLMAAC HADDKLALVN NTQPKRIDLY LALLSAVSAS IKDEKFFENY NQSLEKWSLS QAVTGLIDTG RISEAETLCT KNLKSNPDQP AVILLLRQVQ CKPLLESQKP LPDAVLEELQ KTVMSNSTSV PAWQWLAHVY QSQGMMRAAE MCYRKSLQLA SQRGSWSGKL SSLLRLALLA LKVCMANISN DHWPSLVQEA TTEALKLCFC PLAVLLQALL QFKRKMGARE TRRLLERVVY QPGYPKSIAS TARWYLLRHL YAKDDYELID VLVNNAKTHG DTRALELNQR LSSQ //